FI Fast Break audio news: Nov. 29, 2023
The latest Food Institute news podcast discusses which food and beverage brands resonate with Gen Z consumers.
The latest Food Institute news podcast discusses which food and beverage brands resonate with Gen Z consumers.
Eli Lilly’s Zepbound, recently approved by the FDA, is the most potent weight-loss drug yet. Could it impact the food industry? At least one expert says ‘yes.’
The latest Fast Break Food Institute news podcast touches on “The Ozempic Effect” on the food and beverage industry.
With 17% of children ages 10 to 17 considered obese, consideration is being given to whether diabetes drugs like Ozempic should be made available to kids. Health experts have concerns.
This week’s Food Institute news podcast touches on the latest innovations featured at fast-food drive-thrus.
Several medications approved to treat diabetes are being used as “miracle” weight-loss drugs, and the category continues to grow.
Americans searched for “keto diet plan” an average of 52,000 times per month last year, according to a Total Shape report.
The Sirtfood Diet is regaining some prominence after Adele posted a salad recipe based on the diet, leading spectators to believe ‘sirtfoods’ may be responsible for the singer’s 100-pound weight loss. Blogger ‘The Modern Nonna’ …
U.S. consumer attitudes about health and wellness are shifting. People have stopped focusing on diets and “can’t haves” and are instead paying attention to whole-body health and lifestyle changes they feel will be long-lasting, according …